Interleukin-2 shows high adjuvanticity for an inactivated vaccine against duck Tembusu virus disease

Interleukin-2 shows high adjuvanticity for an inactivated vaccine against duck Tembusu virus disease

Currently, the widely used vaccine against duck Tembusu virus (DTMUV) disease is inactivated vaccine which, however, facing the limits of large inoculation dose, short immunization period, and incomplete effectiveness. Access to efficient adjuvants aiding for DTMUV inactivated vaccine seems to be of...

Full description

Bibliographic Details
Main Authors: Xintao Gao, Xiao Ren, Shan Zhang, Haozhi Song, Xiaoyu Guo, Hong Jia, Ting Xin, Yitong Jiang, Zhifang Zhang, Shaohua Hou
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Poultry Science
Subjects:
duck Tembusu virus
dIL-2
adjuvant
inactivated vaccine
dose
Online Access:http://www.sciencedirect.com/science/article/pii/S0032579120305605

Internet

http://www.sciencedirect.com/science/article/pii/S0032579120305605

Similar Items